Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > Pez is weird

<< Previous

Bullboard Posts

Next >>

Post by Rarbar99on Sep 27, 2021 11:37am

117 Views

Post# 33923994

Pez is weird

Notice how everytime I post a comment, Pez is quick to reply within a matter of minutes. Even after I came back from a 3 week break, he was quick to reply as soon as I said something. He is constantly staring at his screen 24/7 waiting for me to say something, he still has PTSD from the photo I posted of my car. Stop it Pez, get some help. Its just a car.

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China